First USP OK for rHAs a "significant advantage", says Novozymes
5 Minuten
Podcast
Podcaster
Beschreibung
vor 16 Jahren
Two recombinant human albumins made by Novozymes' biopharma
division have become the first to comply with the USP-NF's recently
revised excipient monograph.
division have become the first to comply with the USP-NF's recently
revised excipient monograph.
Weitere Episoden
3 Minuten
vor 11 Jahren
3 Minuten
vor 12 Jahren
5 Minuten
vor 12 Jahren
4 Minuten
vor 12 Jahren
7 Minuten
vor 12 Jahren
In Podcasts werben
Kommentare (0)